Search research articles
Contact Us
Filters
Showing results (1-10 of 95) with videos related to
Page
of 10
Sort By:
Blood
|
August 25, 2018
CAR T cells find strength in polyfunction
Marco L Davila
Science (New York, N.Y.)
|
December 5, 2024
Synthetic gene circuits drive disease-fighting T cells
Marco L Davila, Renier Brentjens
International Journal of Hematology
|
June 6, 2016
Biology and clinical application of CAR T cells for B cell malignancies
Marco L Davila, Michel Sadelain
Hematology/Oncology Clinics of North America
|
April 9, 2013
Chimeric antigen receptor therapy for chronic lymphocytic leukemia: what are the challenges?
Marco L Davila, Renier Brentjens
Best Practice & Research. Clinical Haematology
|
June 19, 2018
CAR T cells, immunologic and cellular therapies in hematologic malignancies
Renier Brentjens, Marco L Davila
Nature Cancer
|
September 19, 2024
Deciphering the response to BCMA CAR T cell therapy
Hamza Hassan, Marco L Davila
Best Practice & Research. Clinical Haematology
|
October 9, 2021
Advances in CAR T cell clinical development
Marco L Davila, Christina Bachmeier
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 1, 2017
CARs Move To the Fast Lane
Marco L Davila, Eirini P Papapetrou
Clinical Lymphoma, Myeloma & Leukemia
|
August 2, 2017
Is Disease-Specific Immunotherapy a Potential Reality for MDS?
David A Sallman, Marco L Davila
Molecular Therapy Oncolytics
|
May 28, 2016
CAR models: next-generation CAR modifications for enhanced T-cell function
Daniel Abate-Daga, Marco L Davila
Page
of 10
Search research articles
Search
Showing results (1-10 of 95) with videos related to
Sort By:
Page
of 10
Blood
|
August 25, 2018
CAR T cells find strength in polyfunction
Marco L Davila
Science (New York, N.Y.)
|
December 5, 2024
Synthetic gene circuits drive disease-fighting T cells
Marco L Davila, Renier Brentjens
International Journal of Hematology
|
June 6, 2016
Biology and clinical application of CAR T cells for B cell malignancies
Marco L Davila, Michel Sadelain
Hematology/Oncology Clinics of North America
|
April 9, 2013
Chimeric antigen receptor therapy for chronic lymphocytic leukemia: what are the challenges?
Marco L Davila, Renier Brentjens
Best Practice & Research. Clinical Haematology
|
June 19, 2018
CAR T cells, immunologic and cellular therapies in hematologic malignancies
Renier Brentjens, Marco L Davila
Nature Cancer
|
September 19, 2024
Deciphering the response to BCMA CAR T cell therapy
Hamza Hassan, Marco L Davila
Best Practice & Research. Clinical Haematology
|
October 9, 2021
Advances in CAR T cell clinical development
Marco L Davila, Christina Bachmeier
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 1, 2017
CARs Move To the Fast Lane
Marco L Davila, Eirini P Papapetrou
Clinical Lymphoma, Myeloma & Leukemia
|
August 2, 2017
Is Disease-Specific Immunotherapy a Potential Reality for MDS?
David A Sallman, Marco L Davila
Molecular Therapy Oncolytics
|
May 28, 2016
CAR models: next-generation CAR modifications for enhanced T-cell function
Daniel Abate-Daga, Marco L Davila
Page
of 10